Bionano Genomics, Inc.
Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) — SEC Financial Statements & Analysis
Bionano Genomics, Inc. (BNGO) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 3 | 3 | 4 | 4 | 9 | 9 | 10 | 16 | 18 | 35 | 15 | |||||
Available For Sale Securities Debt Securities Curr… | 11 | 16 | 19 | 13 | 15 | 0 | 3 | 9 | 13 | 49 | 29 | 62 | |||||
Accounts Receivable Net Current | 4 | 5 | 5 | 3 | 3 | 5 | 5 | 6 | 8 | 9 | 9 | 8 | |||||
Inventory Net | - | - | - | - | - | - | - | - | - | - | - | 32 | |||||
Prepaid Expense And Other Assets Current | 5 | 5 | 5 | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | 5 | |||||
Restricted Cash Current | - | - | - | - | - | - | - | 11 | - | - | - | - | |||||
Restricted Investments Current | - | 10 | 10 | 11 | 11 | 11 | 11 | 0 | 24 | 35 | - | - | |||||
Restricted Cash And Investments Current | 10 | - | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | 39 | 45 | 49 | 43 | 45 | 39 | 47 | 61 | 86 | 140 | 105 | 123 | |||||
Restricted Cash Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 25 | 25 | 23 | 21 | 20 | |||||
Operating Lease Right Of Use Asset | 3 | 3 | 3 | 4 | 1 | 2 | 3 | 4 | 5 | 6 | 6 | 7 | |||||
Finance Lease Right Of Use Asset | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | |||||
Intangible Assets Net Excluding Goodwill | 3 | 4 | 6 | 7 | 8 | 10 | 11 | 30 | 32 | 34 | 36 | 38 | |||||
Other Assets Noncurrent | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 6 | 7 | 7 | 10 | 3 | |||||
Goodwill | - | - | - | - | - | - | - | - | - | 0 | 0 | 77 | |||||
Assets | 65 | 74 | 79 | 76 | 78 | 77 | 87 | 129 | 158 | 214 | 182 | 271 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 5 | 6 | 6 | 6 | 7 | 7 | 9 | 9 | 10 | 10 | 15 | 12 | |||||
Accrued Liabilities Current | 4 | 5 | 5 | 3 | 4 | 6 | 6 | 6 | 11 | 8 | 12 | 8 | |||||
Contract With Customer Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | - | 0 | 10 | 10 | |||||
Liabilities Current | 21 | 23 | 23 | 24 | 26 | 37 | 33 | 37 | 59 | 100 | 40 | 33 | |||||
Operating Lease Liability Noncurrent | 3 | 2 | 3 | 3 | 0 | 0 | 2 | 2 | 3 | 4 | 4 | 5 | |||||
Finance Lease Liability Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 0 | 0 | 6 | 10 | 11 | 15 | 15 | |||||
Liabilities | 27 | 29 | 29 | 31 | 30 | 41 | 38 | 49 | 75 | 118 | 63 | 57 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 765 | 764 | 761 | 749 | 745 | 729 | 720 | 709 | 695 | 677 | 656 | 640 | |||||
Retained Earnings Accumulated Deficit | -728 | -720 | -712 | -703 | -696 | -693 | -673 | -629 | -613 | -581 | -537 | -425 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | -0 | 0 | 0 | 2 | -0 | -0 | 0 | -0 | -0 | |||||
Stockholders Equity | 37 | 44 | 50 | 45 | 48 | 35 | 49 | 80 | 83 | 96 | 119 | 215 | |||||
Liabilities And Stockholders Equity | 65 | 74 | 79 | 76 | 78 | 77 | 87 | 129 | 158 | 214 | 182 | 271 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | |||||
Common Stock Shares Issued | 79 | 75 | 78 | 82 | 87 | 90 | 88 | 71 | 58 | 5 | 5 | 5 | |||||
Shares Outstanding | 79 | 75 | 78 | 82 | 87 | 90 | 88 | 71 | 58 | 1 | 283 | 299 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.40% | -8.00% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 0.27% | -9.89% | -21.12% | 24.30% | -40.19% | -43.93% | 14.29% | 8.16% | -11.56% | -11.64% | -21.23% | -20.55% |
| 2024 | 5.43% | -26.09% | -31.52% | 13.95% | 6.98% | -27.91% | -11.54% | 23.08% | -66.73% | 54.12% | 33.33% | 14.70% |
| 2023 | - | - | - | -7.23% | -26.99% | -69.64% | 22.06% | 38.97% | -10.29% | -6.72% | -33.61% | -10.08% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.84 | 1.98 | 2.12 | 1.76 | 1.70 | 1.06 | 1.43 | 1.63 | 1.46 | 1.40 | 2.60 | 3.66 | |||||
| Quick Ratio | 1.61 | 1.75 | 1.89 | 1.64 | 1.60 | 0.97 | 1.29 | 1.50 | 1.38 | 1.34 | 2.46 | 2.53 | |||||
| Working Capital | 17.75M | 22.44M | 25.82M | 18.48M | 18.52M | 2.15M | 14.03M | 23.39M | 27.11M | 40.09M | 64.34M | 89.08M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.73 | 0.66 | 0.59 | 0.68 | 0.63 | 1.17 | 0.79 | 0.61 | 0.91 | 1.23 | 0.53 | 0.26 | |||||
| Interest Coverage TTM | - | - | - | - | - | -852.32 | -23.31 | -36.59 | -40.37 | -42.05 | -772.27 | -494.13 | |||||
| Debt Ratio | 0.42 | 0.40 | 0.37 | 0.40 | 0.39 | 0.54 | 0.44 | 0.38 | 0.48 | 0.55 | 0.35 | 0.21 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.40 | 0.38 | 0.35 | 0.27 | 0.24 | 0.21 | 0.25 | 0.18 | 0.17 | 0.14 | 0.13 | 0.11 | |||||
| Days Sales Outstanding TTM | 47.55 | 63.71 | 62.54 | 64.87 | 74.80 | 83.44 | 76.57 | 69.19 | 73.51 | 82.57 | 78.72 | 72.18 | |||||
| Receivables Turnover TTM | 7.68 | 5.73 | 5.84 | 5.63 | 4.88 | 4.37 | 4.77 | 5.28 | 4.97 | 4.42 | 4.64 | 5.06 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -2.88 | -2.42 | -3.61 | -10.80 | -15.53 | -22.03 | -23.72 | -45.32 | -64.50 | -102.15 | -100.65 | -72.10 | |||||
| Free Cash Flow Per Share TTM | -1.76 | -1.50 | -1.75 | -3.79 | -8.08 | -13.56 | -16.11 | -23.35 | -34.39 | -55.00 | -71.72 | -81.26 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 46.97% | 46.25% | 45.97% | 5.05% | 1.74% | 1.23% | -1.79% | 28.97% | 27.54% | 26.49% | 26.57% | 25.36% | |||||
| Operating Profit Margin TTM | -114.03% | -116.95% | -127.94% | -262.91% | -285.71% | -337.87% | -350.97% | -509.32% | -556.51% | -595.98% | -677.83% | -465.70% | |||||
| Net Profit Margin TTM | -109.95% | -92.59% | -134.36% | -271.02% | -294.05% | -363.98% | -407.34% | -557.98% | -605.26% | -643.74% | -676.22% | -464.96% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 0.96% | -7.37% | -13.84% | -25.02% | -24.04% | -14.79% | -0.82% | 16.08% | 26.93% | 29.90% | 29.82% | 35.12% | |||||
| Net Income Growth (1Y) | -62.25% | -76.44% | -71.58% | -63.58% | -63.10% | -51.82% | -40.26% | 39.30% | 62.26% | 75.34% | 94.47% | 38.47% | |||||
| EPS Growth (1Y) | -81.47% | -89.00% | -84.76% | -76.17% | -75.92% | -78.43% | -76.43% | -37.15% | -10.07% | 43.74% | 60.97% | 25.54% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.41 | -0.63 | -0.47 | -0.30 | -0.18 | -0.79 | -1.14 | -0.90 | -1.03 | -1.11 | -1.81 | -5.08 | |||||
| P/B | 0.34 | 0.38 | 0.37 | 0.50 | 0.31 | 2.50 | 3.16 | 2.29 | 2.83 | 2.68 | 3.45 | 3.46 | |||||
| P/S TTM | 0.45 | 0.58 | 0.64 | 0.82 | 0.53 | 2.87 | 4.64 | 5.02 | 6.25 | 7.15 | 12.21 | 23.60 | |||||
| Market Cap | 12.85M | 16.66M | 18.26M | 22.57M | 15.03M | 88.46M | 154.55M | 183.76M | 234.17M | 258.10M | 410.53M | 743.76M | |||||
| Enterprise Value | 11.64M | 15.88M | 18.94M | 22.78M | 15.19M | 82.69M | 149.17M | 165.76M | 221.85M | 243.61M | 379.83M | 732.39M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -19.30M | -16.35M | -18.67M | -26.06M | -43.56M | -68.92M | -92.20M | -105.18M | -120.90M | -125.18M | -161.96M | -165.14M | |||||
| Net Debt | -1.20M | -780.00K | 681.00K | 203.00K | 158.00K | -5.77M | -5.38M | -18.00M | -12.32M | -14.49M | -30.70M | -11.37M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data